Werkgroep Cardiologische centra Nederland English

GEMINI (Klaar)

A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects with ACS
Middel
rivaroxaban
Populatie
ASCVD
Fase
II
Jaar aanvang
2014
Meer informatie
ClinicalTrials.gov

GEMINI: Nieuws